SCHEMBL9448244

SCHEMBL9448244

CCC1NCC2CCc3cc(OC)ccc3C2C1OS(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 1/20 0.40
▸ CYP19A1 P11511 2/20 0.40
▸ SRD5A1 P18405 2/20 0.39
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HSD17B2 P37059 1/20 0.36
▸ PPARD Q03181 1/20 0.35
▸ ADRA2A P08913 3/20 0.35
▸ ADRA2B P18089 3/20 0.35
▸ ADRA2C P18825 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9448212 0.86 HTR2C (0.48) HTR2CCYP19A1SRD5A1CA1CA2
SCHEMBL9448097 0.77 HTR2C (0.44) HTR2CCYP19A1SRD5A1CA1CA2
SCHEMBL9448284 0.76 CYP19A1 (0.40) CYP19A1PPARD
SCHEMBL9448236 0.72 SRD5A1 (0.42) HTR2CSRD5A1CA1CA2CA7
SCHEMBL9448061 0.70 SRD5A1 (0.44) HTR2CCYP19A1SRD5A1ALDH1A1CYP1A2
SCHEMBL9448205 0.68 SRD5A1 (0.45) HTR2CCYP19A1SRD5A1CA1CA2
SCHEMBL9448190 0.67 CYP19A1 (0.43) CYP19A1PPARD
SCHEMBL9447903 0.66 HTR2C (0.50) HTR2CCYP19A1SRD5A1
SCHEMBL9447900 0.66 HTR2C (0.50) HTR2CCYP19A1SRD5A1
SCHEMBL12844306 0.66 PPARD (0.54) HTR2CCYP19A1SRD5A1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5248677-A Nervous system disorders or antidepressants ABBOTT LABORATORIES (US) 1993-09-28 — — US disclosed
US-5180733-A Antidepressants or nervous systen disorders ABBOTT LABORATORIES (US) 1993-01-19 — — US disclosed
EP-0461353-A1 Biogenic amine uptake inhibitors ABBOTT LABORATORIES (US) 1991-12-18 — — EP disclosed
Send feedback